|Articles|October 25, 2022
AAPS Conference Highlights 2022
Author(s)Alivia Leon
Advertisement
At the AAPS 2022 conference in Boston, BioPharm International interviewed Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Co. We spoke with Vibha Jawa about her expertise in the field of cell & gene therapies, specifically CAR-T cells. Luke Schenck discussed his knowledge on co-processed APIs. To see the highlights of our interviews with these experts, click the video below.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
2
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
3
Rentschler–Coriolis Partnership Reflects Demand for Connected Biopharma Workflows
4
Implementing Automation and Flexible Design for Allogeneic Manufacturing
5
